Johns Hopkins Investigators Develop Novel Treatment for T-cell Leukemias and Lymphomas

A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and i

Related Keywords

Virginia ,United States ,America ,American ,Sandrab Gabelli ,Michaels Hwang ,Kennethw Kinzler ,Nina Wagner Johnston ,Bert Vogelstein ,Stephanie Glavaris ,Maximilianf Konig ,Sarahr Dinapoli ,Alexanderh Pearlman ,Ephraim Fuchs ,Suman Paul ,Sima Rozati ,Nickolas Papadopoulos ,Chetan Bettegowda ,Nikita Marcou ,Shibin Zhou ,Kathy Gabrielson ,Evangeline Watson ,Tushar Nichakawade ,Nicholas Wyhs ,Seok Lee ,Johns Hopkins ,Lustgarten Foundation For Pancreatic Cancer Research ,Johns Hopkins Kimmel Cancer Center ,American Society Of Hematology Scholar Award ,Johns Hopkins University School Of Medicine ,Ludwig Center ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,Leukemia Lymphoma Society Translation Research Program Award ,Dk Ludwig Fund For Cancer Research ,Swim Across America Translational Cancer Research Award ,National Cancer Institute ,Lustgarten Laboratory ,Commonwealth Fund ,Johns Hopkins University ,Johns Hopkins University School ,Bum Seok Lee ,Cole Sterling ,Lode Swinnen ,Surojit Sur ,Cancer Research ,Lustgarten Foundation ,Pancreatic Cancer Research ,Kimmel Institute ,Bloomberg Philanthropies ,National Institutes ,American Society ,Hematology Scholar Award ,Swim Across America Translational Cancer Research ,Newswise ,Ohns Hopkins Kimmel Cancer Center Suman Pault Cells Lymphoma Leukemia Antibody Drug Conjugate ,All Journal News ,Johns Hopkins Medicine ,